Kanjinti

List of products in the National Drug Code with proprietary name kanjinti. Trastuzumab is used to treat certain breast or stomach cancers that produce more than the normal amount of a certain substance called HER2 protein. Trastuzumab belongs to a class of medications known as monoclonal antibodies. It works by slowing or stopping the growth of cancer cells. This monograph is about the following trastuzumab products: trastuzumab, trastuzumab-anns, trastuzumab-dkst, trastuzumab-dttb, trastuzumab-pkrb, trastuzumab-qyyp.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
55513-132Kanjinti Trastuzumab-annsInjection, Powder, Lyophilized, For SolutionIntravenousAmgen IncHuman Prescription Drug
55513-141Kanjinti Trastuzumab-annsInjection, Powder, Lyophilized, For SolutionIntravenousAmgen IncHuman Prescription Drug
55513-164Kanjinti Trastuzumab-annsKitAmgen IncHuman Prescription Drug